StephenDouglasSmithMD

PubMed

• 2 citations
  A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials.
  Jeffrey R Whiteaker, Lei Zhao, Regine M Schoenherr, Dongqing Huang, Rachel A Lundeen
  Frontiers in Oncology. 2023-01-01
• 92 citations
  Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapy.
  Victor A. Chow, Ajay K. Gopal, David G. Maloney, Cameron J. Turtle, Stephen D. Smith
  American Journal of Hematology. 2019-05-21
• 31 citations
  Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphoma.
  Ryan C Lynch, Chaitra S Ujjani, Christina Poh, Edus H Warren, Stephen D Smith
  Blood. 2023-05-25

Journal Articles

• Twice‐Weekly Ixazomib in Combination with Lenalidomide‐Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma  
  Myo Htut, Michaela Liedtke, Stephen D Smith, Craig C Hofmeister, Rachid Baz, Paul G Richardson, Cara A Rosenbaum, David H Vesole, Ajai Chari, Jesus G Berdeja, Noopur Raje, British Journal of Haematology

Abstracts/Posters

• A Phase 2 Study of the Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in Relapsed/Refractory Peripheral T-Cell Lymphoma and C...
  Stephen D. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin Lymphoma
  Stephen D. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Relapsed or Refractory CLL after CD19-Specific CAR-T Therapy: Treatment Patterns and Clinical Outcomes
  Stephen D. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Low Achievement of End of Life Quality Measures in Large B-Cell Lymphoma Patients Who Progressed after CD19-Specific CAR-T Cell Therapy
  Stephen D. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Ibrutinib in Relapsed or Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma: Final Results from a Prospective Phase II Study
  Stephen D. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classic...
  Stephen D. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials
  Stephen D. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Impact of Lab Abnormalities at the Time of Progression in Patients Receiving CD19-Specific CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas
  Stephen D. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...
  Stephen D. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
  Stephen D. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• CD20 Targeted CAR-T for High-Risk B-Cell Non-Hodgkin Lymphomas
  Stephen D. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Rapid and Durable Responses with the SYK/JAK Inhibitor Cerdulatinib in a Phase 2 Study in Relapsed/Refractory Follicular Lymphoma„Alone or in Combination with Rituximab 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Exploring the Present and Future of BTK Inhibition in B-Cell Malignancies: Expert Insights on Practical Implications for Patient Management 
  60th American Society of Hematology Annual Meeting - 11/30/2018